Publications by authors named "David P Conrad"

Claim this Profile
C
Combinatorial cancer immunotherapy strategies with proapoptotic small-molecule IAP antagonists.
Shawn T Beug, David P Conrad, Tommy Alain, Robert G Korneluk, Eric C Lacasse

Int J Dev Biol· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
VEGF-Mediated Induction of PRD1-BF1/Blimp1 Expression Sensitizes Tumor Vasculature to Oncolytic Virus Infection.
Rozanne Arulanandam, Cory Batenchuk, Fernando A Angarita, Kathryn Ottolino-Perry, Sophie Cousineau, David P Conrad

Cancer Cell· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Microtubule disruption synergizes with oncolytic virotherapy by inhibiting interferon translation and potentiating bystander killing.
Rozanne Arulanandam, Cory Batenchuk, Oliver Varette, Chadi Zakaria, Vanessa Garcia, David P Conrad

Nat Commun· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leukemia cell-rhabdovirus vaccine: personalized immunotherapy for acute lymphoblastic leukemia.
David P Conrad, Jovian Tsang, Meaghan Maclean, Jean-Simon Diallo, Fabrice Le Boeuf

Clin Cancer Res· July 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harnessing oncolytic virus-mediated antitumor immunity in an infected cell vaccine.
Chantal G Lemay, Julia L Rintoul, Agnieszka Kus, Jennifer M Paterson, Vanessa Garcia, David P Conrad

Mol Ther· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis